213. VYBOROChNOE FARMAKOEPIDEMIOLOGIChESKOE ISSLEDOVANIE REVMATOIDNOGO ARTRITA.

Por A L Khokhlov, O V Ershova
Publicado em 2000-08-01

Clinical and economic constituents of the application of dexamethasone and tocilizumab in the therapy for severe conditions in patients with COVID-19

Por O. V. Zhukova, A. L. Khokhlov
Publicado em 2021-04-01

Genetic testing for forecasting and course of the chronic heart failure against the background arterial hypertension

Por A. L. Khokhlov, Yu. V. Rybachkova
Publicado em 2018-02-01

Analysis of the quality of bioequivalence and pharmacokinetics studies in Russia Federation

Por A. L. Khokhlov, E. G. Lileeva
Publicado em 2018-05-01

COMPARATIVE ANALYSIS OF DRUG EFFICACY IN THE TREATMENT FOR COVID-19 SEVERE FORMS, BASED ON ATTRIBUTE-BASED STATISTIC METHODS AND ANALYSIS OF DRUG INTERACTIONS

Por O. V. Zhukova, I. N. Kagramanyan, A. L. Khokhlov
Publicado em 2021-03-01

Planning and Evaluation of Bioequivalence Studies of Telmisartan Generic Drug Products

Por A. L. Khokhlov, D. P. Romodanovsky, A. E. Miroshnikov
Publicado em 2019-09-01

SILVER NANOPARTICLES IN THE SOLUTION OF THE PROBLEM OF DRUG RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS

Por A. V. Zaharov, A. L. Khokhlov, A. E. Ergeshov
Publicado em 2017-05-01

Planning and Evaluation of Bioequivalence Studies of Enalapril Products

Por D. P. Romodanovsk, A. L. Khokhlov, A. E. Miroshnikov
Publicado em 2018-12-01

Planning Bioequivalence Studies in the Context of the COVID-19 Pandemic

Por D. P. Romodanovsky, A. L. Khokhlov, D. V. Goryachev
Publicado em 2021-03-01

PHARMACOEPIDEMIOLOGY OF PHYSICIANS’ INDICATIONS IN PATIENTS WITH POSTINFARCTIONCARDIOSCLEROSIS

Por O. N. Kurochkinа, A. L. Khokhlov, N. M. Boyankova
Publicado em 2015-03-01

FEATURES OF THE CLINICAL SIGNIFICANCE OF POLYMORPHIC VARIANTS OF ENOS AND AGTR2 GENES IN PATIENTS WITH CAD

Por A. L. Khokhlov, N. O. Pozdnyakov, A. E. Miroshnikov, I. N. Tzareva, S. O. Pozdnyakov
Publicado em 2016-06-01

METHODS OF STABILIZATION OF DRUG SUBSTANCES AND THEIR METABOLITES IN BIOLOGICAL FLUIDS DURING BIOANALYTICAL STUDY (REVIEW)

Por I. I. Yaichkov, A. L. Khokhlov, Y. A. Dzhurko, L. N. Shitov, A. A. Trubnikov
Publicado em 2019-01-01

EFFECTIVENESS OF COMBINATION OF ISONIAZID AND SILVER NANOPARTICLES IN THE TREATMENT OF EXPERIMENTAL TUBERCULOSIS

Por A. V. Zаkhаrov, A. E. Ergeshov, A. L. Khokhlov, B. S. Kibrik
Publicado em 2017-06-01

OBITUARY FOR YURI N. CHERNOV 5 Nov 1937 – 1 Jan 2021

Por M. V. Vasin, I. E. Esaulenko, V. G. Kukes, V. I. Petrov, I. B. Ushakov, A. L. Khokhlov
Publicado em 2021-06-01

PHARMACOGENETIC FEATURES OF THERAPY OF PATIENTS WITH ATHEROSCLEROSIS

Por A. L. Khokhlov, A. N. Yavorsky, N. O. Pozdnyakov, J. V. Rybachkova, E. S. Emelianov, A. A. Khokhlov, A. E. Miroshnikov, S. O. Pozdnyakov
Publicado em 2018-02-01

Pharmacokinetic and Bioequivalence Study of Telzap AM^® (Telmisartan/amlodipine Fixed-dose Combination) and Coadministered Mikardis^® (Telmisartan) and Norvas...

Por V. Kubesh, A. L. Khokhlov, A. M. Shitova, Yu. A. Dzhurko, V. I. Kazey, A. A. Khokhlov, A. E. Miroshnikov, O. V. Lebedeva, I. K. Klaus, A. V. Zyatenkov
Publicado em 2020-11-01